SUMMARY The efficacy of pentobarbital in the delayed treatment of acute cerebral ischemia was investigated in cats. Cerebral ischemia was produced by left middle cerebral artery (LMCA) ligation. Ten cats received 50 mg/kg of pentobarbital prior to ligation; a second group of 10 cats received the same dose of pentobarbital 2 hrs after ligation, and the control group of 7 cats received no pentobarbital. Brains were removed after spontaneous or induced death and the volume infarction was determined histologically. It was found that the volume of brain infarction in the group receiving pentobarbital 2 hrs after ligation was significantly less than that of the control group, which received no pentobarbital; but the volume of infarction in the former group was significantly greater than that found in the experimental group, which received pentobarbital prior to ligation. However, the mortality after LMCA ligation was higher in the 2 experimental groups, which received pentobarbital therapy, than in the control group, which did not receive pentobarbital. An hypothesis was advanced, which speculated that secondary adrenal insufficiency and altered cardiovascular function accounted for the increased mortality after pentobarbital treatment of patients with ischemic stroke.
"
3 However, if pentobarbital is to be useful in the treatment of patients with acute occlusion of cerebral arteries, it must be effective when administered after arterial obstruction has occurred. 4 This realization, together with the observation by Little el al. h that during the first 3 hrs of cerebral ischemia only slight microcirculatory impairment was detected in the affected brain tissue, provoked the present work. In the present study, the volume of resultant brain necrosis after left middle cerebral artery (LMCA) ligation was determined when pentobarbital was administered 2 hrs after occlusion. These results were compared with those obtained from 2 other experimental groups subjected to the same kind of ischemic stroke; 1 received no pentobarbital (control group) and the other received pentobarbital prior to arterial ligation.
Methods
Twenty-seven healthy adult cats, weighing between 2.2 and 3.7 kg, were utilized in the present study; they were paralyzed with succinylcholine and maintained on a Harvard Apparatus Respirator (model 607) during the surgical procedure. Both femoral veins and a branch of the femoral artery were cannulated under local anesthesia with lidocaine. Femoral arterial pressure was recorded continuously on a Grass Polygraph (model 7) connected to the arterial cannula via a Grass Pressure Transducer (model P23DC). Mean arterial pressure was maintained at 105 ± 6 mm Hg by replacement of all lost blood with blood from donor cats; during pentobarbital administration, an infusion of levarterenol bitartrate was necessary to maintain this level of blood pressure. Physiological saline was administered intravenously throughout each experiment to replace fluid losses. Ampicillin and chloramphenicol were administered in therapeutic dosages throughout the first 3 days of experiments. The hematocrits were maintained in the range of 25-40%; the normal range for cats is 24-45%. 6 Arterial blood gases were measured hourly for the duration of each experiment, and were maintained within the following ranges: Pao 2 110 ± 20 mm Hg, Paco 2 28 ± 7 mm Hg, pH 7.41 ± 0.05. Lead II of the ECG was recorded continuously on a Holter Monitor Electrocardiocorder (Avionics Model 400). These ECG records subsequently were reviewed by passing the magnetic tapes through an Avionics Model 650 Composite Electrocardioscanner. During experiments, cardiac rate and rhythm were observed directly on a Tektronix Physiological Monitor (Type 410). Rectal temperatures were maintained in the range of 99.8-102.4 F; the normal range for cats is 100.4-102.2 F. 7 Animals were divided into 3 experimental groups. Group I consisted of 7 cats which received no pentobarbital. Group II included 10 cats anesthetized with 50 mg/kg pentobarbital 1 hr prior to the occlusion of the left middle cerebral artery (LMCA). Group III consisted of 10 cats which received 50 mg/kg of pentobarbital 2 hrs after ligation. All pentobarbital was administered intravenously as a bolus. To neutralize the highly basic pentobarbital, a predetermined amount of HC1 was injected at the same time as the pentobarbital but in a different venous cannula.
The ligation of the LMCA was accomplished with a modification of the method of Sundt and Waltz. 8 The LMCA was exposed under local anesthesia in Groups I and III, and under pentobarbital anesthesia in Group II.
The location and extent of brain lesions caused by the occlusion of LMCA were determined by the subsequently described procedure, which is based primarily on histological study of hematoxylin and eosin stained brain sections. After spontaneous or induced death, the chest was opened and the descending aorta ligated. A catheter was inserted into the aorta, and the head perfused with normal saline, followed by 10% formal-saline. Then the brain was removed, and examined grossly to rule out the presence of 246 STROKE VOL 9 , No 3, MAY-JUNE 1978 intracranial hemorrhage; it was then sliced in the frontal plane at intervals of 4 mm. The slices were made to pass through easily recognizable landmarks, such as the optic chiasma, mammillary bodies, the midbrain, the pons, and the medulla. These brain slices were examined grossly to determine the general location of the cerebral infarction, and to determine if any hemorrhage was present. Representative sections of each brain slice were mounted and stained and the margin between infarcted and healthy tissue was verified with light microscopy.
Estimation of the volume of brain infarction was achieved by the following procedures:
1) The volume of brain slices, which were unaffected by the infarction process, were measured directly by the displacement of fluid in a graduated cylinder.
2) Brain slices with infarcted areas were analyzed by a combination of volume displacement and polar planimetry of photographs of histologic sections from these slices made to the same scale. The volume of the half slice from the side, which was contralateral to the infarction, was determined by fluid displacement as in #1. The determined areas of the uninfarcted tissue on the two faces of the ipsilateral half slice were added, divided by 2, and multiplied by the thickness of the slice. The infarcted volume was calculated by subtracting the uninfarcted volume of the half slice on the ipsilateral side, from the volume of the half slice on the contralateral side. This method is based on the assumption that the 2 sides are bilaterally symmetrical.
3) The total original brain volume was obtained by adding the volume determined by fluid displacement, the uninfarcted volume determined by polar planimetry, and the original volume of brain destroyed by infarction calculated by the method described in §2. Division of the volume of brain, which was infarcted, by the total original brain volume, yielded the fraction of brain infarcted.
This method of analysis of brains is superior to previously used methods of infarct volume determination in that the volume of necrosis is measured indirectly by measuring the remaining uninfarcted brain volume. The volume of an ischemic region changes with the elapsed time after the onset of ischemia, at first being enlarged by edema and then later collapsed due to necrosis. Thus, when the ischemic area is measured directly, the determined volume of infarction depends upon the elapsed time from the onset of ischemia. With our indirect method, we measured only the volume of non-ischemic tissue; therefore, the result is much less affected by edema and/or shrinkage of ischemic brain tissue.
Because ischemic changes in brain tissue cannot be demonstrated with certainty with hematoxylin and eosin staining prior to 24 hrs after the onset of ischemia, the described analysis of brains was carried out only on brains of animals, which lived 24 hrs or longer after ligation of the LMCA. The Mest was utilized to determine significant differences among the experimental groups in the volume of brain which was destroyed by LMCA ligation.
Results
Of the 7 cats in group I (control group), one died of a fatal cardiac arrhythmia 18 hrs after LMCA ligation and 4 other control cats had major cardiac arrhythmias which were not fatal. Throughout the post-ligation period, blood gases (Pao 2 , Paco 2 and pH) and serum electrolytes were maintained at normal levels; therefore none of the cardiac arrhythmias was due to blood gas or electrolyte abnormalities. In group I, the volume of brain destroyed was 17.2 ± 5.87% (N = 6) of the original brain volume. Pertinent data from group I, including the values of the blood gases and hematocrits obtained within 1 hr of death, are presented in table 1.
Of the 10 cats in group II (i.e., those receiving 50 mg/kg pentobarbital 1 hr prior to ligation), rigorous support with an i.v. infusion of levarterenol was necessary to maintain blood pressure within normal limits at the time of pentobarbital administration. The body temperature tended to decrease after pentobarbital administration, and it had to be supported. Furthermore, it was necessary to decrease the respiratory rate to approximately one-half of the original rate to maintain normal blood gases (i.e., to prevent respiratory alkalosis). Two cats in group II died of fatal cardiac arrhythmias during the first 24 hrs, and 5 others died in 35-50 hrs after ligation of shock of apparent cardiovascular origin (i.e., a gradual decrease in heart rate and blood pressure over 3-5 hrs); support with intravenous levarterenol delayed but did not prevent the cardiovascular collapse. Three cats of this group recovered consciousness, locomotion and feeding behavior despite slight hemiplegia in 2-3 days. In contrast, the control animals (group I) ran an indolent course, with slow recovery of poor quality. The volume of brain destroyed in group II was 1.49 ± 0.73% Of the 10 cats which received 50 mg/kg pentobarbital 2 hr after ligation (group III), 6 died within 42 hrs of apparent cardiovascular shock (table 3) . The other 4 cats died in 3-5 days without regaining consciousness. The volume of brain destroyed in group III was 6.20 ± 3.00% (N = 7) of the original brain volume. This volume of necrosis is significantly less than that of group I {P < 0.01), but is significantly greater than that found in group II (/» < 0.001); these relationships are demonstrated graphically in figure 1 . Unlike the control group (group I) but similar to group II, the brain necrosis in group III tended to be limited to the deeper cerebral structures, sparing the cerebral cortex ( fig.  2 ). Pertinent data from group III, including the values of the blood gases and hematocrits obtained within 1 hr of death, are presented in table 3. 
Discussion
When administered 2 hrs after ligation of the LMCA, pentobarbital significantly decreased the volume of brain infarction in the cat. The protective action of pentobarbital may be due to depression of cerebral metabolism, reduction of cerebral edema, or due to a more specific effect which has not been clearly elucidated. Little et al. 6 demonstrated that following MCA occlusion in squirrel monkeys blood flow in ischemic tissue remained relatively stable during the initial 2-3 hrs after ligation. Since Little et al. 5 used pentobarbital to anesthetize their animals, these data also offer a good explanation for the beneficial effects of pentobarbital when administered after the onset of stroke. That cortical areas are better protected by pentobarbital than deeper structures is again consistent with the observations of Little et al. 6 Impairment of microvascular filling occurred initially in the basal ganglia, and only later did impairment extend outwards to the claustrum, island cortex and cerebral cortex.
The drawback of pentobarbital administration in cats with acute cerebral ischemia is the high incidence of mortality. Death generally occurred 1 to 3 days after pentobarbital administration and appeared to be due to the following 2 causes: (1) cardiac arrhythmias secondary to LMCA occlusion and; (2) shock of cardiovascular origin (i.e., a gradual concurrent decrease in heart rate and blood pressure over 3-5 hr) . It has been previously demonstrated that ischemic stroke due to LMCA ligation in cats secondarily results in a high incidence of major cardiac arrhythmias. 9 The administration of pentobarbital at such high doses is accompanied by a greatly reduced metabolic rate as evidenced by the tendency toward decreased body temperature and progressive respiratory alkalosis. The shock of apparent cardiovascular origin is probably not due to the direct effect of pentobarbital on the heart alone because shock occurred 13 hrs or longer after the occurrence of peak pentobarbital plasma concentrations. Shock was not due to metabolic acidosis because arterial blood gases were within normal ranges until the time of death (see tables 1, 2, and 3), and the shock state developed over 3-5 hrs prior to death. Surgical trauma and sepsis were unlikely causes of the shock syndrome because it only occurred in groups II and III, which received pentobarbital treatment, and never in the control group. Furthermore, sepsis was also an unlikely cause of shock because broad spectrum antibiotic coverage was maintained during the first 3 days of experiments, and the onset of shock occurred in all cases between 15-72 hr after ligation.
The decreasing blood pressure and heart rate of the developing shock syndrome were relatively unresponsive to the intravenous infusion of levarterenol. The latter observation may be explained by a relative lack of glucocorticoids, which are necessary for norepinephrine to be effective. We have observed that plasma cortisol concentrations were either normal or decreased in 3 cats subjected to ischemic strokes by means other than ligation of the LMCA (unpublished observations). Furthermore, it may be speculated that high dose pentobarbital therapy may suppress cortisol elaboration by the adrenal cortex, because the metabolism in general is depressed after pentobarbital treatment.
Based on the foregoing discussion, we hypothesize that the combined effect of ischemic stroke and high dose pentobarbital treatment result in depression of adrenal gland function; as a result, cardiovascular function may become depressed (i.e., decreased heart rate and blood pressure) secondary to adrenal insufficiency and the stroke itself, and result in decreased tissue perfusion, local hypoxia, and ultimately death. This hypothesis is supported by the work of other investigators 10 in which dexamethasone was effective in decreasing the mortality in gerbils subjected to ischemic stroke, and in which pentobarbital had been administered. In cats subjected to acute cerebral ischemia, we have demonstrated that the plasma half-life of pentobarbital is PENTOBARBITAL FOR ISCHEMIC STROKE/fl/ac*. Weidler et al.
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greatly prolonged over that found in normal cats (unpublished observations). Furthermore, the administration of dexamethasone at the same time as pentobarbital in cats subjected to acute cerebral ischemia results in a plasma halflife of pentobarbital which is not significantly different from normal (unpublished observations). Dexamethasone, however, does not reduce the volume of brain infarction." Therefore, it appears that dexamethasone may counteract adrenal insufficiency in one of the following two ways (or a combination of them): (1) It may supply additional circulating glucocorticoids and; (2) by reversion of the half-life of pentobarbital to its normal duration in LMCA occluded cats, it may permit the adrenal cortex to recover more quickly from the barbiturate suppression.
In view of the deleterious side effects of the administration of high doses of pentobarbital, we feel a clinical trial of barbiturate therapy in acute cerebral ischemia must await the development of a protocol which avoids the severe druginduced complications which accompany high plasma barbiturate concentrations. Furthermore, a thorough understanding of the altered pharmacokinetics of pentobarbital in cerebral ischemia must be secured before clinical trials in this therapeutic area can begin.
